Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04845217 · ClinicalTrials.gov registry record · Phase 1

Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome

A Phase 1 study of Interstitial Cystitis, sponsored by University of Louisville.

Recruiting
Registry status
Phase 1
Development phase
100
Enrollment target
1
Study location

NCT04845217 is a Phase 1 study of Interstitial Cystitis that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 100 participants, below the 358-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04845217, a Phase 1 study of Interstitial Cystitis, is actively recruiting participants, sponsored by University of Louisville.

RECRUITING
Registry status
Phase 1
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the use of peppermint oil as a treatment for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).

Conditions Studied

Interventions

  • DRUG Peppermint oil
  • DRUG Coconut Oil

Study Locations (1)

Kentucky

  • Springs Medical Center - Louisville

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2021-09-15
Est. Completion 2023-12
Phase Phase 1

Sponsor

University of Louisville

217 total trials

What the Registry Record Tells You About NCT04845217

The ClinicalTrials.gov registry entry for NCT04845217 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 358-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (72% lower). The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Interstitial Cystitis appearing as the primary indexed condition, and to 2 interventions - of which Peppermint oil is the first listed.

NCT04845217 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT04845217 about?

NCT04845217 is a clinical study titled "Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome". The purpose of this study is to assess the use of peppermint oil as a treatment for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).

What is the current status of trial NCT04845217?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2021-09-15. Estimated completion is 2023-12.

What conditions does trial NCT04845217 study?

This clinical trial studies the following conditions: Interstitial Cystitis.

What interventions are being tested in trial NCT04845217?

The interventions under investigation include: Peppermint oil (DRUG), Coconut Oil (DRUG).

Who is sponsoring clinical trial NCT04845217?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04845217 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Interstitial Cystitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.